Activity of a heat-induced reformulation of amphotericin B deoxycholate (Fungizone) against Leishmania donovani

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 2, 1999, Pages 390-392

  Petit, C ^a   Yardley, V ^b   Gaboriau, F ^a,c   Bolard, J ^a   Croft, S L ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX;

ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ARTICLE; FEMALE; LEISHMANIA DONOVANI; MAMMAL CELL; MOUSE; MYCOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0033035461     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.2.390     Document Type: Article

References (28)

1. Berman, J. D., G. Ksionski, W. L. Chapman, V. B. Waits, and W. L. Hanson. 1992. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrob. Agents Chemother. 36:1978-1980.
2. Berman, J. D., W. L. Hanson, W. L. Chapman, C. K. Alving, and G. Lopez-Berestein. 1986. Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys. Antimicrob. Agents Chemother. 30:847-851.
3. Brajtburg, J., and J. Bolard. 1996. Carrier effects on biological activity of amphotericin B. Clin. Microbiol. Rev. 9:512-531.
4. Croft, S. L., J. A. Urbina, and R. Brun. 1997. Chemotherapy of human leishmaniasis and trypanosomiasis, p. 245-257. In G. Hide, J. C. Mottram. G. H. Coombsand, and P. H. Holmes (ed.), Trypanosomiasis and leishmaniasis, CAB International, Oxon, United Kingdom.
5. Croft, S. L., R. N. Davidson, and E. A. Thornton. 1991. Liposomal amphotericin B in the treatment of visceral leishmaniasis. J. Antimicrob. Chemother. 28(Suppl. B):111-118.
6. Davidson, K. N., L. Di Martino, L. Gradoni, R. Giacchino, R. Russo, G. B. Gaeta, R. Pempinello, S. Scott, F. Raimondi, A. Cascio, et al. 1994. Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multi-center trial. Q. J. Med. 87:75-81.
7. Davidson, R. N., L. di Martino, L. Gradoni, R. Giacchino, G. B. Gaeta, R. Pempinello, S. Scotti, A. Cascio, E. Castagnola, A. Maisto, M. Gramiccia, D. di Caprio, R. J. Wilkinson, and A. D. Bryceson. 1996. Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome). Clin. Infect. Dis. 22:938-943.
8. Davidson, R. N., S. L. Croft, A. Scott, M. Maini, A. H. Moody, and A. D. Bryceson. 1991. Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 337:1061-1062.
9. De Marie, S., R. Janknegt, and I. A. J. M. Bakker-Woudenberg. 1994. Clinical use of liposomal and lipid-complexed amphotericin B. J. Antimicrob. Chemother. 33:907-916.
10. Dietze, R., E. P. Milan, J. D. Berman, M. Grogl, A. Falqueto, T. F. Feitosa, K. G. Luz, F. A. Suassuna, L. A. Marinho, and G. Ksionski. 1993. Treatment of Brazilian kala-azar with a short course of Amphocil (amphotericin B cholesterol dispersion). Clin. Infect. Dis. 17:981-986.
11. Gaboriau, F., M. Cheron, L. Leroy, and J. Bolard. 1997. Physico-chemical properties of the heat-induced 'superaggregates' of amphotericin B. Biophys. Chem. 66:1-12.
12. Gaboriau, F., M. Cheron, C. Petit, and J. Bolard. 1997 Heat induced su peraggregation of amphotericin B reduces its in vitro toxicity: a new way to improve its therapeutic index. Antimicrob. Agents Chemother. 41:2345-2351.
13. Gangneux, J. P., A. Sulahian, Y. J. Garin, and F. Derouin. 1996. Lipid formulations of amphotericin B in the treatment of experimental visceral leishmaniasis due to Leishmania infantum. Trans. R. Soc. Trop. Med Hyg. 90:574-577.
14. Gangneux, J. P., A. Sulahian, V. J. Garin, R. Farinotti, and F. Derouin. 1996. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrob. Agents. Chemother. 40: 1214-1218.
15. Hartsel, S., and J. Bolard. 1996. Amphotericin B: new life for an old drug. TiPS 17:445-449.
16. Janknegt, R., S. de Marie, I. A. J. M. Bakker-Woudenberg, and D. J. A. Crommelin. 1992. Liposomal and lipid formulations of amphotericin B. Clin. Pharmacokinet. 23:279-291.
17. Legrand, P., E. A. Romero, B. E. Cohen, and J. Bolard. 1992 Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrob. Agents Chemother. 36:2518-2522.
18. New, R. R., M. L. Chance, and S. Hearth. 1981. Antileishmanial activity of amphotericin B and other antifungal agents entrapped in liposomes. J. Antimicrob. Chemother. 8:371-381.
19. Petit, C., M. Cheron, V. Joly, J. M. Rodrigues, Jr., J. Bolard, and F. Gaboriau. 1998. In vivo therapeutic efficacy in experimental murine mycoses of a new formulation of deoxycholate-amphotericin B (Fungizone®) obtained by mild heating. J. Antimicrob. Chemother. 42:779-785.
20. Ramos, H., J. Brajtburg, V. Marquez, and B. E. Cohen. 1995. Comparison of the leishmanicidal activity of Fungizone, liposomal AmB and amphotericin B incorporated into egg lecithin-bile salt mixed micelles. Drugs Exp. Clin. Res. 21:211-216.
21. Seaman, J., C. Boer, R. Wilkinson, J. de Jong, E. de Wilde, E. Sondorp, and R. Davidson. 1995. Liposomal amphotericin B (AmBisome) in the treatment of complicated kala-azar under field conditions. Clin. Infect. Dis. 21:188-193.
22. Sundar, S., and H. W. Murray. 1996. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex. J. Infect. Dis. 173:762-765.
23. Sundar, S., N. K. Agrawal, P. R. Sinha, G. S. Horwith, and H. W. Murray. 1997. Short-course, low dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann. Intern. Med. 127:133-137.
24. Thakur, C. P., A. K. Pandey, G. P. Sinha, S. Roy, K. Behbehani, and P. Olliaro. 1996. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. Trans. R. Soc. Trop. Med. Hyg. 90:319-322.
25. Vertut-Doï, A., S. I. Ohnishi, and J. Bolard. 1994. The endocytic process in CHO cells, a toxic pathway of the polyene antibiotic amphotericin B. Antimicrob. Agents Chemother. 38:2373-2379.
26. Wasan, K. M., and G. Lopez-Berestein. 1997. Diversity of lipid-based polyene formulations and their behavior in biological systems. Eur. J. Clin. Microbiol. Infect. Dis. 16:81-92.
27. World Health Organization. 1990. Control of leishmaniasis. Publication 793. World Health Organization, Geneva, Switzerland.
28. Yardley, V., and S. L. Croft. 1997. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis. Antimicrob. Agents Chemother. 41:752-756.